Innovative Treatment Promise Valencia's eCOIN device offers a long-term, minimally invasive solution for urinary incontinence, appealing to patients seeking effective and hassle-free treatment options that reduce the need for repeated procedures or medication.

Strong Market Validation The recent approval of a Category III CPT code and partnership with the American Urological Association enhance provider adoption opportunities and position Valencia's solution as a standard of care in symptomatic urinary incontinence management.

Growing Financial Backing The company secured a substantial $35 million investment, indicating strong investor confidence and potential for expanding sales efforts, product development, and market reach.

Expanding Leadership Recent executive hires, including a new Vice President of Sales and a Vice President of Procedural Training, demonstrate focus on sales growth, provider training, and strategic market expansion.

Targeted Market Segment Valencia’s primary customers are hospitals, surgical centers, and outpatient clinics focused on minimally invasive urological treatments, representing key opportunities for partnerships and expanding adoption among healthcare providers seeking efficient, cost-effective solutions.